We will be happy to help you, if you
Dr. Uta-Bettina von Altenbockum:
Head of Public Relations
Phone +49 69 92915-47
Following the German government's investment in the biotechnology company CureVac, known as the vaccine platform and currently the leader in the development of a vaccine against Covid-19, the company is now planning an IPO in New York. This example shows that Germany is still not an attractive location for IPOs of young growth companies and that politicians finally need to act.
Our topics at a glance: